GNPX CIK: 1595248

Genprex, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
–
FY22:
21.5
FY23:
7.53
FY24:
2.08
FY25:
8.36
(positive)
Change from FY22 to FY25
millions USD
FY22:
–
FY22:
3.61
FY23:
3.14
FY24:
2.05
FY25:
1.80
Total assets
Change from FY22 to FY25
millions USD
FY22:
29.9
FY22:
25.1
FY23:
10.7
FY24:
4.12
FY25:
10.2

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
–
FY22:
2.81
FY23:
3.25
FY24:
2.50
FY25:
2.17
(negative)
millions USD
FY22:
–
FY22:
0
FY23:
0
FY24:
0
FY25:
0.02
(positive)
Change from FY22 to FY25
millions USD
FY22:
27.5
FY22:
22.3
FY23:
7.42
FY24:
1.62
FY25:
7.96
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
29.9
FY22:
25.1
FY23:
10.7
FY24:
4.12
FY25:
10.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data